Cambridge Investment Research Advisors’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $22.8M | Buy |
45,487
+2,742
| +6% | +$1.32M | 0.05% | 377 |
|
|
2026
Q1 | $21M | Buy |
42,745
+2,873
| +7% | +$1.56M | 0.05% | 363 |
|
|
2025
Q4 | $23.1M | Sell |
39,872
-2,480
| -6% | -$1.4M | 0.06% | 313 |
|
|
2025
Q3 | $20.5M | Buy |
42,352
+960
| +2% | +$447K | 0.06% | 336 |
|
|
2025
Q2 | $16.8M | Buy |
41,392
+3,238
| +8% | +$1.35M | 0.05% | 370 |
|
|
2025
Q1 | $19M | Buy |
38,154
+691
| +2% | +$374K | 0.06% | 298 |
|
|
2024
Q4 | $19.5M | Buy |
37,463
+4,045
| +12% | +$2.22M | 0.07% | 287 |
|
|
2024
Q3 | $20.7M | Buy |
33,418
+2,909
| +10% | +$1.72M | 0.07% | 273 |
|
|
2024
Q2 | $16.9M | Sell |
30,509
-3,346
| -10% | -$1.92M | 0.06% | 310 |
|
|
2024
Q1 | $19.7M | Sell |
33,855
-1,054
| -3% | -$591K | 0.08% | 253 |
|
|
2023
Q4 | $18.5M | Sell |
34,909
-8,219
| -19% | -$3.98M | 0.08% | 248 |
|
|
2023
Q3 | $21.8M | Buy |
43,128
+6,055
| +16% | +$3.23M | 0.1% | 196 |
|
|
2023
Q2 | $19.3M | Sell |
37,073
-463
| -1% | -$250K | 0.09% | 228 |
|
|
2023
Q1 | $21.6M | Sell |
37,536
-951
| -2% | -$536K | 0.11% | 201 |
|
|
2022
Q4 | $21.2M | Sell |
38,487
-3,310
| -8% | -$1.75M | 0.11% | 187 |
|
|
2022
Q3 | $21.2M | Buy |
41,797
+1,200
| +3% | +$672K | 0.12% | 179 |
|
|
2022
Q2 | $22.1M | Sell |
40,597
-885
| -2% | -$487K | 0.12% | 182 |
|
|
2022
Q1 | $24.5M | Sell |
41,482
-816
| -2% | -$469K | 0.11% | 190 |
|
|
2021
Q4 | $28.2M | Buy |
42,298
+5,617
| +15% | +$3.51M | 0.13% | 172 |
|
|
2021
Q3 | $21M | Sell |
36,681
-5,819
| -14% | -$3.19M | 0.1% | 198 |
|
|
2021
Q2 | $21.4M | Sell |
42,500
-2,316
| -5% | -$1.09M | 0.1% | 204 |
|
|
2021
Q1 | $20.5M | Buy |
44,816
+3,712
| +9% | +$1.77M | 0.11% | 191 |
|
|
2020
Q4 | $19.1M | Buy |
41,104
+3,494
| +9% | +$1.64M | 0.11% | 186 |
|
|
2020
Q3 | $16.6M | Buy |
37,610
+2,057
| +6% | +$850K | 0.11% | 188 |
|
|
2020
Q2 | $12.9M | Buy |
35,553
+1,086
| +3% | +$364K | 0.1% | 214 |
|
|
2020
Q1 | $9.78M | Buy |
34,467
+10,747
| +45% | +$3.39M | 0.09% | 203 |
|
|
2019
Q4 | $7.71M | Buy |
23,720
+321
| +1% | +$97.3K | 0.06% | 321 |
|
|
2019
Q3 | $6.82M | Sell |
23,399
-1,098
| -4% | -$314K | 0.06% | 309 |
|
|
2019
Q2 | $7.19M | Buy |
24,497
+1,461
| +6% | +$402K | 0.07% | 285 |
|
|
2019
Q1 | $6.3M | Buy |
23,036
+5,698
| +33% | +$1.42M | 0.06% | 295 |
|
|
2018
Q4 | $3.88M | Sell |
17,338
-844
| -5% | -$198K | 0.04% | 408 |
|
|
2018
Q3 | $4.44M | Buy |
18,182
+1,089
| +6% | +$251K | 0.04% | 407 |
|
|
2018
Q2 | $3.54M | Buy |
17,093
+1,796
| +12% | +$381K | 0.04% | 442 |
|
|
2018
Q1 | $3.16M | Buy |
15,297
+2,967
| +24% | +$623K | 0.04% | 469 |
|
|
2017
Q4 | $2.34M | Buy |
12,330
+1,737
| +16% | +$333K | 0.03% | 534 |
|
|
2017
Q3 | $2M | Sell |
10,593
-2,061
| -16% | -$373K | 0.03% | 540 |
|
|
2017
Q2 | $2.21M | Buy |
12,654
+1,984
| +19% | +$333K | 0.03% | 473 |
|
|
2017
Q1 | $1.64M | Buy |
10,670
+437
| +4% | +$66.8K | 0.03% | 514 |
|
|
2016
Q4 | $1.44M | Buy |
10,233
+1,196
| +13% | +$176K | 0.03% | 537 |
|
|
2016
Q3 | $1.44M | Buy |
9,037
+1,503
| +20% | +$232K | 0.03% | 533 |
|
|
2016
Q2 | $1.11M | Buy |
7,534
+832
| +12% | +$123K | 0.02% | 560 |
|
|
2016
Q1 | $949K | Sell |
6,702
-632
| -9% | -$84.7K | 0.02% | 590 |
|
|
2015
Q4 | $1.04M | Buy |
7,334
+1,022
| +16% | +$136K | 0.02% | 528 |
|
|
2015
Q3 | $772K | Buy |
6,312
+830
| +15% | +$108K | 0.02% | 571 |
|
|
2015
Q2 | $711K | Buy |
5,482
+366
| +7% | +$47.7K | 0.02% | 649 |
|
|
2015
Q1 | $687K | Sell |
5,116
-901
| -15% | -$116K | 0.02% | 649 |
|
|
2014
Q4 | $754K | Buy |
6,017
+8
| +0.1% | +$973 | 0.02% | 587 |
|
|
2014
Q3 | $731K | Buy |
6,009
+814
| +16% | +$99K | 0.02% | 634 |
|
|
2014
Q2 | $613K | Buy |
5,195
+128
| +3% | +$15.1K | 0.02% | 654 |
|
|
2014
Q1 | $609K | Sell |
5,067
-149
| -3% | -$17.7K | 0.02% | 618 |
|
|
2013
Q4 | $581K | Buy |
5,216
+303
| +6% | +$30.1K | 0.02% | 594 |
|
|
2013
Q3 | $453K | Buy |
4,913
+153
| +3% | +$13.8K | 0.02% | 671 |
|
|
2013
Q2 | $403K | Buy |
+4,760
| New | +$396K | 0.02% | 635 |
|
Other funds holding TMO
Cambridge Investment Research Advisors's TMO Position: Q2 2026 in Review
Cambridge Investment Research Advisors increased its Thermo Fisher Scientific (TMO) stake by 6.4% in Q2 2026, buying an estimated $1.32M and bringing the position to 45,487 shares worth $22.8M. The position accounts for 0.05% of the portfolio, ranked #377.
Cambridge Investment Research Advisors first reported a position in TMO in Q2 2013 and has held it in 53 quarters since. The position peaked at $28.2M in Q4 2021. 2,604 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Cambridge Investment Research Advisors held 45,487 shares of Thermo Fisher Scientific worth $22.8M as of Q2 2026.
- Cambridge Investment Research Advisors bought 2,742 Thermo Fisher Scientific shares in Q2 2026, an estimated $1.32M.
- Thermo Fisher Scientific made up 0.05% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #377 holding.
- Cambridge Investment Research Advisors first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 53 quarters since.
- Cambridge Investment Research Advisors's Thermo Fisher Scientific position peaked at $28.2M in Q4 2021.
- 2,604 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.